Cargando…
Retraction Note: α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
Autores principales: | Zhao, Y., Wei, A., Zhang, H., Chen, X., Wang, L., Yu, X., Yuan, Q., Zhang, J., Wang, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046717/ https://www.ncbi.nlm.nih.gov/pubmed/32107372 http://dx.doi.org/10.1038/s41389-020-0211-6 |
Ejemplares similares
-
α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
por: Zhao, Y, et al.
Publicado: (2017) -
Retraction Note: Alginate oligosaccharide attenuates α2,6- sialylation modification to inhibit prostate cancer cell growth via the Hippo/YAP pathway
por: Han, Yang, et al.
Publicado: (2021) -
Retraction Note: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway
por: Zhang, Rui, et al.
Publicado: (2023) -
Retraction Note: Alteration of astrocytes and Wnt/β-catenin signaling in the frontal cortex of autistic subjects
por: Cao, Fujiang, et al.
Publicado: (2016) -
Retraction Note: TRIM29 facilitates the epithelial‑to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
por: Sun, Juntao, et al.
Publicado: (2022)